Equities

KNC Laboratories Co Ltd

6568:TYO

KNC Laboratories Co Ltd

Actions
Basic MaterialsChemicals
  • Price (JPY)1,163.00
  • Today's Change-3.00 / -0.26%
  • Shares traded11.90k
  • 1 Year change-27.90%
  • Beta1.1076
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments3,3122,2971,974
Total Receivables, Net2,6262,7912,518
Total Inventory2,5182,2801,772
Prepaid expenses604733
Other current assets, total434550
Total current assets8,5597,4596,347
Property, plant & equipment, net8,4757,2006,909
Goodwill, net------
Intangibles, net536446
Long term investments344233254
Note receivable - long term------
Other long term assets39113127
Total assets18,62215,40513,952
LIABILITIES
Accounts payable300306278
Accrued expenses663490535
Notes payable/short-term debt0500200
Current portion long-term debt/capital leases658440440
Other current liabilities, total1,348993594
Total current liabilities2,9692,7282,047
Total long term debt1,3125971,037
Total debt1,9701,5371,677
Deferred income tax------
Minority interest------
Other liabilities, total1,254335293
Total liabilities5,5353,6593,377
SHAREHOLDERS EQUITY
Common stock1,9951,9951,995
Additional paid-in capital1,9061,8951,895
Retained earnings (accumulated deficit)9,0697,8306,568
Treasury stock - common(68)(78)(0.05)
Unrealized gain (loss)185103116
Other equity, total0.000.000.00
Total equity13,08711,74510,575
Total liabilities & shareholders' equity18,62215,40513,952
Total common shares outstanding7.727.717.78
Treasury shares - common primary issue0.060.070.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.